Growth Hormone Deficiency: Symptoms Parents Should Not Ignore

Growth hormone deficiency may be present from birth (congenital) or develop later in childhood (acquired). Congenital cases can be associated with structural differences in the pituitary gland or surrounding brain structures. Acquired cases may follow head injury, inflammation, tumours affecting the hypothalamic-pituitary region, or cranial radiotherapy. In some children, no clear cause is identified. Some children have isolated growth hormone deficiency, meaning only GH production is affected. Others may have multiple pituitary hormone deficiencies, requiring broader endocrine monitoring and management [11][12].

Symptoms Parents Should Not Ignore

The hallmark sign of growth hormone deficiency in children is slowed growth over time rather than an abrupt change. Many children with growth hormone deficiency appear otherwise healthy, which can make early recognition more challenging [13]. Slow growth is usually defined by reduced growth velocity – meaning fewer centimetres gained per year than expected for age. For example, a growth velocity of less than 4cm a year in childhood, and less than 6-7cm a year in puberty, might indicate growth failure that needed explaining and – consistent growth below this range may prompt further assessment [14]. In infants, signs can look different. Some babies with congenital growth hormone deficiency may experience persistent low blood sugar or prolonged neonatal jaundice. These features are uncommon but can form part of the clinical picture [15].

It is important to stress that many short children do not have growth hormone deficiency. Some are constitutionally small, and others are following a genetic pattern consistent with parental height. The concern arises when a child’s growth pattern changes or slows relative to their previous trajectory. For example, a child who has always followed the 9th centile may be entirely healthy. A child who drops from the 50th to the 9th centile over time requires assessment. This gradual fall away from their established centile on the growth chart is key [16][17][18]

Other signs of growth hormone deficiency include children who have a relatively younger-looking face compared with peers, or those who experience delayed tooth development.

When to Seek Medical Advice

Parents are often the first to notice subtle changes in their child’s growth pattern. While children grow at different rates – and temporary plateaus can occur – it is sensible to seek medical advice if there is a sustained slowing of growth over six to twelve months, particularly if your child appears to be crossing down centile lines on their growth chart [6]. Parents may also wish to consult your GP or a paediatrician if your child’s annual height gain appears noticeably below average (for instance, less than around 4-5 cm per year during mid-childhood), or if they seem significantly shorter than classmates despite average-height parents [6]. A large difference between a child’s projected adult height and their genetic target height (based on parental stature) can also prompt further evaluation [19].

Certain medical histories warrant earlier review. These include:

• Previous significant head injury
• Brain tumours or surgery affecting the hypothalamic-pituitary region
  
• Cranial radiotherapy (for example, treatment for childhood cancers)
• Central nervous system infections, such as meningitis or encephalitis
• Known genetic or midline structural conditions [4]

In addition, if slowed growth occurs alongside other symptoms – such as delayed puberty, excessive tiredness, persistent headaches, visual disturbance, increased thirst or urination, or symptoms suggestive of thyroid dysfunction – prompt medical assessment is advisable [4]. While these features are not specific to growth hormone deficiency, they may indicate broader endocrine or neurological causes that require investigation.

It is important to emphasise that seeking medical advice does not mean a serious diagnosis is inevitable. In fact, most children referred for short stature are found to have normal variants of growth, such as familial short stature or constitutional delay of growth and puberty. In these cases, reassurance, monitoring and time are often all that is required.

However, where growth hormone deficiency in children is identified, earlier diagnosis allows earlier access to specialist care and, if appropriate, growth hormone therapy. Clinical studies consistently show that treatment initiated sooner is associated with improved growth velocity and better adult height outcomes [20].

How Growth Is Assessed and Diagnosed 

Diagnosis follows structured national and international guidance, including recommendations from organisations such as the National Institute for Health and Care Excellence [4][16]. The first step is accurate serial height measurement over time. Without reliable data plotted correctly, a diagnosis cannot be made. Children grow at different rates, particularly during infancy and puberty. For this reason, clinicians rely on growth velocity – the rate of height gain over time – rather than a single measurement [17][18].

Blood tests are typically performed to exclude other causes of poor growth, including thyroid dysfunction, coeliac disease, chronic inflammatory conditions and anaemia. Levels of IGF-1 may be measured as a supportive marker, though they are not diagnostic alone [13].

Because growth hormone is secreted in pulses, a random blood test is not useful. Instead, children undergo growth hormone stimulation testing in a controlled hospital setting. Medications are administered to stimulate GH release, and blood samples are taken at intervals to assess peak response. Blunted responses across validated tests support the diagnosis [13]. If deficiency is confirmed, MRI imaging of the hypothalamic-pituitary region is usually recommended to assess for structural abnormalities [13]. This process requires careful interpretation by paediatric endocrine specialists. 

Treatment and Long-Term Outlook

The standard treatment for confirmed growth hormone deficiency in children is recombinant human growth hormone, administered as a daily subcutaneous injection. Decades of clinical trials and registry data demonstrate that treatment significantly increases growth velocity, particularly in the first year of therapy [6].

When initiated early, many children achieve adult heights within their predicted genetic range. Treatment is usually continued until growth plates close in late adolescence. Monitoring includes regular height measurements, weight checks and IGF-1 levels to ensure appropriate dosing. Side effects are uncommon but can include headaches, joint discomfort or, rarely, increased intracranial pressure. Ongoing specialist supervision ensures safe management [6].

Beyond height, research indicates benefits in body composition, bone mineral density and exercise capacity [10], with one study finding 15% decreases in fat mass and 10-12% increases in lean mass. Psychosocial well-being often improves as children feel more aligned with peers in stature. Additionally, children with multiple pituitary hormone deficiencies require longer-term endocrine follow-up into adulthood.